Home / Inspections / 1289844

FDA Inspection 1289844 — Novartis Pharma Schweizerhalle Ag

Novartis Pharma Schweizerhalle Ag — FEI 3002865753

The FDA completed an inspection of Novartis Pharma Schweizerhalle Ag on March 27, 2025 in Pratteln. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 27, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pratteln (Switzerland)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1180967 (NAI Thu Aug 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1018347 (VAI Fri Jun 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 938183 (NAI Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 810431 (NAI Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 672696 (VAI Fri Jul 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources